Pamela G. Robey

Bone formation by human postnatal bone marrow stromal stem cells is enhanced by telomerase expression.

Normal vision despite narrowing of the optic canal in fibrous dysplasia.

Telomerase accelerates osteogenesis of bone marrow stromal stem cells by upregulation of CBFA1, osterix, and osteocalcin.

Thyroid carcinoma in the McCune-Albright syndrome: contributory role of activating Gs alpha mutations.

Dental characteristics of fibrous dysplasia and McCune-Albright syndrome.

Fibrous dysplasia in the spine: prevalence of lesions and association with scoliosis.

Fracture incidence in polyostotic fibrous dysplasia and the McCune-Albright syndrome.

A novel technique based on a PNA hybridization probe and FRET principle for quantification of mutant genotype in fibrous dysplasia/McCune-Albright syndrome.

Extracellular matrix proteoglycans control the fate of bone marrow stromal cells.

Skeletal site-specific characterization of orofacial and iliac crest human bone marrow stromal cells in same individuals.

The mechanical phenotype of biglycan-deficient mice is bone- and gender-specific.

Pegvisomant for the treatment of gsp-mediated growth hormone excess in patients with McCune-Albright syndrome.

Parathyroid-specific double knockout of Gq and G11 alpha-subunits leads to a phenotype resembling germline knockout of the extracellular Ca2+ -sensing receptor.

Sensitive and specific method for detecting G protein-coupled receptor mRNAs.

Long-term outcome of optic nerve encasement and optic nerve decompression in patients with fibrous dysplasia: risk factors for blindness and safety of observation.

Exercise-induced changes in the cortical bone of growing mice are bone- and gender-specific.

Onset, progression, and plateau of skeletal lesions in fibrous dysplasia and the relationship to functional outcome.

In vitro model of bromodeoxyuridine or iron oxide nanoparticle uptake by activated macrophages from labeled stem cells: implications for cellular therapy.

Long-term stable canine mandibular augmentation using autologous bone marrow stromal cells and hydroxyapatite/tricalcium phosphate.

WITHDRAWN: Familial Degenerative Encephalopathy with Intracranial Calcification and Metaphyseal Dysplasia.

Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production.

Enumeration of the colony-forming units-fibroblast from mouse and human bone marrow in normal and pathological conditions.

Cytotoxicity mediated by the Fas ligand (FasL)-activated apoptotic pathway in stem cells.

In vivo transfer of intracellular labels from locally implanted bone marrow stromal cells to resident tissue macrophages.

Microstructure and mineral composition of dystrophic calcification associated with the idiopathic inflammatory myopathies.

Superparamagnetic iron oxide nanoparticles labeling of bone marrow stromal (mesenchymal) cells does not affect their "stemness".

Global transcriptome analysis of human bone marrow stromal cells (BMSC) reveals proliferative, mobile and interactive cells that produce abundant extracellular matrix proteins, some of which may affect BMSC potency.

A mosaic activating mutation in AKT1 associated with the Proteus syndrome.

Modulation of canonical Wnt signaling by the extracellular matrix component biglycan.

Wnt/β-catenin signaling is differentially regulated by Gα proteins and contributes to fibrous dysplasia.

The establishment of a bank of stored clinical bone marrow stromal cell products.

Stromal-derived IL-6 alters the balance of myeloerythroid progenitors during Toxoplasma gondii infection.

BRD4 is an atypical kinase that phosphorylates serine2 of the RNA polymerase II carboxy-terminal domain.

Regulation and expression of the ATP-binding cassette transporter ABCG2 in human embryonic stem cells.

Non-colony type monolayer culture of human embryonic stem cells.

Stem cells in the face: tooth regeneration and beyond.

The meaning, the sense and the significance: translating the science of mesenchymal stem cells into medicine.

Regulation of stem cell therapies under attack in Europe: for whom the bell tolls.

Intra-subject variability in human bone marrow stromal cell (BMSC) replicative senescence: molecular changes associated with BMSC senescence.

WISP1/CCN4: a potential target for inhibiting prostate cancer growth and spread to bone.

Establishing a bone marrow stromal cell transplant program at the National Institutes of Health Clinical Center.

Biglycan modulates angiogenesis and bone formation during fracture healing.

Comparison of the molecular profiles of human embryonic and induced pluripotent stem cells of isogenic origin.

Human pluripotent stem cell culture: considerations for maintenance, expansion, and therapeutics.

Bone marrow mesenchymal stromal cells to treat tissue damage in allogeneic stem cell transplant recipients: correlation of biological markers with clinical responses.

Developmental insights from early mammalian embryos and core signaling pathways that influence human pluripotent cell growth and differentiation.

Constitutive Expression of Gsα(R201C) in Mice Produces a Heritable, Direct Replica of Human Fibrous Dysplasia Bone Pathology and Demonstrates Its Natural History.

Path to the clinic: assessment of iPSC-based cell therapies in vivo in a nonhuman primate model.

Directed differentiation of human induced pluripotent stem cells toward bone and cartilage: in vitro versus in vivo assays.

A randomized, double blind, placebo-controlled trial of alendronate treatment for fibrous dysplasia of bone.